Skip to content

PHARMACIE DROULEZ: what changed

What changed

PHARMACIE DROULEZ

BE 0823.341.344
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€81,368
2024 · €40,253+€41,115
Equity
€306,787
2024 · €395,422-€88,635
Cash
€220,898
2024 · €277,557-€56,660
Balance sheet total
€522,272
2024 · €472,884+€49,388

Largest movements

2024 to 2025
Assets
  • Current investments +€100,003

    up €100,003 (+24,796%), from €403 to €100,406

  • Cash -€56,660

    down €56,660 (-20.4%), from €277,557 to €220,898

    mainly Contributions, distributions and other (-€170,003) and Current investments (-€100,003)

  • Receivables within one year +€11,887

    up €11,887 (+22.5%), from €52,828 to €64,715

    of which Trade receivables: +€20,740

Equity and liabilities
  • Other debts +€128,818

    up €128,818 (+313%), from €41,186 to €170,003

  • Reserves -€88,635

    down €88,635 (-22.8%), from €389,222 to €300,587

  • Tax, wage and social debts +€11,679

    up €11,679 (+231%), from €5,045 to €16,724

Income statement
  • Gross operating margin +€33,949

    up €33,949 (+35.0%), from €97,048 to €130,997

  • Taxes +€18,558

    up €18,558 (+86.4%), from €21,472 to €40,030

  • Depreciation -€16,550

    down €16,550 (-77.5%), from €21,345 to €4,796

  • Other operating charges -€8,355

    down €8,355 (-90.1%), from €9,272 to €918

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €40,253
Gross operating margin +€33,949
Depreciation +€16,550
Other operating charges +€8,355
Financial income -€14
Financial charges +€834
Taxes -€18,558
Result 2025 €81,368
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€218,896
Investment -€105,553
Financing -€170,003
Cash 2024 €277,557
Net result for the year +€81,368
Depreciation +€4,796
Stocks and contracts +€3,269
Receivables within one year -€11,887
Deferred charges and accrued income +€3,328
Trade debts -€2,474
Tax, wage and social debts +€11,679
Other debts +€128,818
Investment in fixed assets (net) -€5,550
Current investments -€100,003
Contributions, distributions and other -€170,003
Cash 2025 €220,898
brings cash intakes cash out
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €472,884 €522,272 +€49,388 +10.4%
Fixed assets 21/28 €31,724 €32,479 +€754 +2.4%
Intangible fixed assets 21 €0 €0 =
Tangible fixed assets 22/27 €31,724 €32,479 +€754 +2.4%
Land and buildings 22 €0 - =
Plant, machinery and equipment 23 €16,789 €15,880 -€908 -5.4%
Furniture and vehicles 24 €633 €3,649 +€3,015 +476%
Other tangible fixed assets 26 €14,302 €12,949 -€1,352 -9.5%
Current assets 29/58 €441,160 €489,794 +€48,634 +11.0%
Stocks and contracts in progress 3 €105,355 €102,086 -€3,269 -3.1%
Stocks 30/36 €105,355 €102,086 -€3,269 -3.1%
Amounts receivable within one year 40/41 €52,828 €64,715 +€11,887 +22.5%
Trade receivables 40 €38,736 €59,476 +€20,740 +53.5%
Other amounts receivable 41 €14,092 €5,240 -€8,853 -62.8%
Current investments 50/53 €403 €100,406 +€100,003 +24,796%
Cash at bank and in hand 54/58 €277,557 €220,898 -€56,660 -20.4%
Deferred charges and accrued income 490/1 €5,016 €1,689 -€3,328 -66.3%
Total equity and liabilities 10/49 €472,884 €522,272 +€49,388 +10.4%
Equity 10/15 €395,422 €306,787 -€88,635 -22.4%
Contributions 10/11 €6,200 €6,200 = 0.0%
Reserves 13 €389,222 €300,587 -€88,635 -22.8%
Distributable reserves 133 €389,222 €300,587 -€88,635 -22.8%
Amounts payable 17/49 €77,462 €215,485 +€138,023 +178%
Amounts payable within one year 42/48 €77,462 €215,485 +€138,023 +178%
Trade debts 44 €31,231 €28,757 -€2,474 -7.9%
Suppliers 440/4 €31,231 €28,757 -€2,474 -7.9%
Taxes, remuneration and social security 45 €5,045 €16,724 +€11,679 +231%
Taxes 450/3 €5,045 €16,724 +€11,679 +231%
Other amounts payable 47/48 €41,186 €170,003 +€128,818 +313%
Non-recurring operating income 76A - €3,960 +€3,960
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €21,345 €4,796 -€16,550 -77.5%
Other operating charges 640/8 €9,272 €918 -€8,355 -90.1%
Gross operating margin 9900 €97,048 €130,997 +€33,949 +35.0%
Operating profit (loss) 9901 €66,430 €125,283 +€58,853 +88.6%
Financial income 75/76B €19 €6 -€14 -71.7%
Recurring financial income 75 €19 €6 -€14 -71.7%
Financial charges 65/66B €4,724 €3,890 -€834 -17.7%
Recurring financial charges 65 €4,724 €3,890 -€834 -17.7%
Profit (loss) for the period before taxes 9903 €61,726 €121,399 +€59,673 +96.7%
Income taxes 67/77 €21,472 €40,030 +€18,558 +86.4%
Profit (loss) for the period 9904 €40,253 €81,368 +€41,115 +102%
Profit (loss) for the period to be appropriated 9905 €40,253 €81,368 +€41,115 +102%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 6 November 2026 via checked.be.